2022 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Cardiovascular
Publications
3
Total Publications
1
Abstract/Manuscript
2
Oral Presentation
2020 · Oral Presentation · No · Methods/Pharmacoepi
Real world treatment patterns following the initiation of proprotein convertase subtilisin/kexin type 9 antibody inhibitors among adults in the United States, 2015-2019
Read more →2020 · Oral Presentation · No · Methods/Pharmacoepi
History of lipid lowering therapy use among adults initiating treatment with proprotein convertase subtilisin/kexin type 9 antibody inhibitors in the United States, 2015-2019
Read more →
Contact us
By submitting this form, you consent to your information used by Headwater Science for the purpose of contacting you to better understand your potential interest in Headwater Science and/or its services. For more information, see our privacy policy.

Pedestal Health projects leverage Headwater Science methods, technology and causal inference expertise where the analytical complexity is highest, comparative effectiveness studies that require dynamic treatment design, regulatory-grade external control work, methodological consultation on submission packages, and the kinds of bias-protection frameworks that consequential evidence increasingly requires.
Pedestal Health projects leverage Headwater Science methods, technology and causal inference expertise where the analytical complexity is highest, comparative effectiveness studies that require dynamic treatment design, regulatory-grade external control work, methodological consultation on submission packages, and the kinds of bias-protection frameworks that consequential evidence increasingly requires.
![News — Real-World Evidence [RWE] Demonstrates Repatha's Long-Term Cardiovascular Benefi | Grid](/_next/image/?url=https%3A%2F%2Fimages.ctfassets.net%2Ffea4lj2cdgl5%2F2CjXmZvISyYEKOkKHVw7Vb%2F0c10368e303aab08a9966f18753021d0%2Fnews-real-world-evidence-rwe-demonstrates-repatha-s-long-term-cardiovascular-benefits-portrait.jpg&w=3840&q=75)